Get the Stockscreener App
4.65
0.43%
-0.02
Zevra Therapeutics Inc Stock (ZVRA) Forecast
The Zevra Therapeutics Inc (ZVRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.8911, representing a +5.19% increase from the current price of $4.65. The highest analyst price target is $5.7612, and the lowest is $4.021.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ZVRA Price Target
Average 5.3908
(+15.93% Upside)
Is Zevra Therapeutics Inc (ZVRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.53 | Neutral |
| STOCH(9,6) | 28.91 | Neutral |
| STOCHRSI(14) | 75.09 | Neutral |
| MACD(12,26) | -0.0883 | Buy |
| ADX(14) | 24.80 | Neutral |
| William %R | -68.97 | Neutral |
| CCI(14) | 13.37 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.6295
Buy
|
4.6556
Sell
|
| MA20 |
4.7858
Sell
|
4.7129
Sell
|
| MA50 |
4.8845
Sell
|
4.9546
Sell
|
| MA100 |
5.5279
Sell
|
5.172
Sell
|
| MA200 |
5.2077
Sell
|
5.2648
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, ZVRA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 9 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on ZVRA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.53 indicates that ZVRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.91 indicates that ZVRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 75.09 indicates that ZVRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.8 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 13.37 indicates that ZVRA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ZVRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Zevra Therapeutics Inc financial reports and earnings history, Zevra Therapeutics Inc (ZVRA) stock could reach $4.5147 by 2030, $3.8464 by 2040 and $3.2652 by 2050. See the projected annual prices until 2050 of the Zevra Therapeutics Inc stock below:
- Zevra Therapeutics Inc (ZVRA) is expected to reach an average price of $3.3176 in 2035, with a high prediction of $4.4765 and a low estimate of $3.0076. This indicates an $-28.65% rise from the last recorded price of $4.65.
- Zevra Therapeutics Inc (ZVRA) stock is projected to chart a bullish course in 2040, with an average price target of $3.6864, representing an $-20.72% surge from its current level. The forecast ranges from a conservative $2.0516 to a sky-high $3.8464.
- Our analysts predict Zevra Therapeutics Inc (ZVRA) to jump -41.51% by 2045, soaring from $2.5096 to an average price of $2.7196, potentially reaching $3.5937. While $2.5096 is the low estimate, the potential upside is significant.
- Zevra Therapeutics Inc (ZVRA) stock is expected to climb by 2050, reaching an average of $2.0975, a $-54.89% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.2652 and $1.7202, respectively, highlighting the market's uncertainty.
Zevra Therapeutics Inc Stock (ZVRA) Year by Year Forecast
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2024
Our forecast for ZVRA stock price in 2024 now indicates an average price target of $5.565 with a high forecast of $7.28 and a low forecast of $3.85. The average prediction reflects an increase of +19.68% from the last recorded price of $4.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2024 | $4.8415 | $4.021 | $5.7612 | +4.12% |
| August, 2024 | $4.902 | $4.592 | $6.0618 | +5.42% |
| September, 2024 | $4.6325 | $4.3925 | $4.9821 | -0.38% |
| October, 2024 | $4.7731 | $4.5327 | $5.3029 | +2.65% |
| November, 2024 | $4.9336 | $4.5534 | $5.3436 | +6.10% |
| December, 2024 | $4.274 | $4.244 | $4.9737 | -8.09% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2025
Zevra Therapeutics Inc Stock (ZVRA) is expected to reach an average price of $5.3684 in 2025, with a high prediction of $7.0867 and a low estimate of $3.65. This indicates an +15.45% rise from the last recorded price of $4.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.9547 | $3.7147 | $4.5147 | -14.95% |
| February, 2025 | $4.7651 | $3.6948 | $4.8001 | +2.48% |
| March, 2025 | $6.3556 | $4.4255 | $6.4856 | +36.68% |
| April, 2025 | $5.5963 | $5.4061 | $6.9558 | +20.35% |
| May, 2025 | $6.4367 | $5.4365 | $7.0867 | +38.42% |
| June, 2025 | $5.8072 | $5.5771 | $6.907 | +24.89% |
| July, 2025 | $4.3278 | $4.1978 | $6.1575 | -6.93% |
| August, 2025 | $4.40 | $3.65 | $4.615 | -5.38% |
| September, 2025 | $5.881 | $4.2502 | $6.041 | +26.47% |
| October, 2025 | $5.0022 | $3.822 | $5.9812 | +7.57% |
| November, 2025 | $5.1432 | $4.4625 | $5.5625 | +10.61% |
| December, 2025 | $4.3544 | $4.2992 | $5.8637 | -6.36% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2026
The predicted value for Zevra Therapeutics Inc (ZVRA) in 2026 is set at an average of $5.1717. Estimates vary from a peak of $6.8935 to a trough of $3.45, indicating an +11.22% surge from the present price of $4.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.4254 | $4.1949 | $4.6247 | -4.83% |
| February, 2026 | $4.6764 | $4.3506 | $5.1059 | +0.57% |
| March, 2026 | $4.4674 | $4.3569 | $5.1471 | -3.93% |
| April, 2026 | $3.9486 | $3.7783 | $4.6976 | -15.08% |
| May, 2026 | $3.9496 | $3.4996 | $4.3193 | -15.06% |
| June, 2026 | $4.6905 | $3.9098 | $4.8905 | +0.87% |
| July, 2026 | $5.5318 | $4.231 | $6.7615 | +18.96% |
| August, 2026 | $5.3927 | $5.2121 | $5.8126 | +15.97% |
| September, 2026 | $6.694 | $5.243 | $6.8935 | +43.96% |
| October, 2026 | $5.415 | $5.205 | $6.2942 | +16.45% |
| November, 2026 | $4.1359 | $4.0057 | $5.1052 | -11.06% |
| December, 2026 | $4.9007 | $3.45 | $5.1223 | +5.39% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Zevra Therapeutics Inc (ZVRA) is $4.9358, with a high forecast of $6.5673 and a low forecast of $3.3043. This indicates an +6.15% increase from the last price of $4.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.8022 | $4.4922 | $5.8415 | +3.27% |
| February, 2027 | $4.4437 | $3.6229 | $5.3637 | -4.44% |
| March, 2027 | $4.9355 | $4.354 | $5.6655 | +6.14% |
| April, 2027 | $4.287 | $4.1013 | $4.9259 | -7.81% |
| May, 2027 | $4.6085 | $3.9974 | $4.7085 | -0.89% |
| June, 2027 | $4.6703 | $4.1603 | $4.9088 | +0.44% |
| July, 2027 | $4.1118 | $3.9718 | $4.9507 | -11.57% |
| August, 2027 | $3.8932 | $3.5825 | $4.2521 | -16.27% |
| September, 2027 | $4.1751 | $3.3043 | $4.3851 | -10.21% |
| October, 2027 | $4.3865 | $4.0365 | $4.6958 | -5.67% |
| November, 2027 | $5.138 | $4.3269 | $6.5673 | +10.49% |
| December, 2027 | $6.2799 | $5.0495 | $6.5199 | +35.05% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2028
In 2028, Zevra Therapeutics Inc (ZVRA) is projected to reach an average price of $4.9144, with a high projection of $6.7002 and a low estimate of $3.1286. This indicates an +5.69% rise from the last price of $4.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.5213 | $5.1913 | $6.7002 | +18.74% |
| February, 2028 | $4.2428 | $4.2228 | $5.9017 | -8.76% |
| March, 2028 | $4.1533 | $3.8135 | $4.4932 | -10.68% |
| April, 2028 | $4.8115 | $3.25 | $4.9224 | +3.47% |
| May, 2028 | $3.4339 | $3.4239 | $5.642 | -26.15% |
| June, 2028 | $4.2459 | $3.4244 | $5.1649 | -8.69% |
| July, 2028 | $4.3078 | $3.9978 | $5.4674 | -7.36% |
| August, 2028 | $4.0903 | $3.7998 | $4.3883 | -12.04% |
| September, 2028 | $4.1823 | $3.9408 | $4.7118 | -10.06% |
| October, 2028 | $4.3442 | $3.9637 | $4.7542 | -6.58% |
| November, 2028 | $3.4267 | $3.3867 | $4.3847 | -26.31% |
| December, 2028 | $3.3686 | $3.1286 | $3.9286 | -27.56% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2029
The 2029 price forecast for Zevra Therapeutics Inc Stock (ZVRA) is $4.7785 on average, with a high prediction of $6.507 and a low estimate of $3.05. This represents an +2.76% increase from the previous price of $4.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.3011 | $3.1091 | $4.5011 | -7.50% |
| February, 2029 | $5.163 | $3.8421 | $6.373 | +11.03% |
| March, 2029 | $5.015 | $4.8241 | $5.5735 | +7.85% |
| April, 2029 | $5.857 | $4.856 | $6.507 | +25.96% |
| May, 2029 | $4.9894 | $4.9794 | $6.3279 | +7.30% |
| June, 2029 | $3.7514 | $3.6214 | $5.5799 | -19.33% |
| July, 2029 | $3.80 | $3.05 | $4.015 | -18.28% |
| August, 2029 | $4.8631 | $3.6506 | $5.4425 | +4.58% |
| September, 2029 | $4.4055 | $3.2249 | $4.9737 | -5.26% |
| October, 2029 | $4.8186 | $3.8661 | $5.0586 | +3.63% |
| November, 2029 | $3.761 | $3.7054 | $5.2692 | -19.12% |
| December, 2029 | $3.8335 | $3.6023 | $4.0316 | -17.56% |
Zevra Therapeutics Inc Stock (ZVRA) Price Forecast for 2030
Zevra Therapeutics Inc Stock (ZVRA) is expected to reach an average price of $4.5819 in 2030, with a high forecast of $6.3137 and a low forecast of $2.85. This signifies an -1.47% decrease from the last price of $4.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3965 | $3.7591 | $4.5147 | -5.45% |
| February, 2030 | $3.839 | $3.759 | $4.5578 | -17.44% |
| March, 2030 | $3.3614 | $3.1908 | $3.8796 | -27.71% |
| April, 2030 | $3.3639 | $2.9139 | $3.7333 | -27.66% |
| May, 2030 | $3.792 | $3.3245 | $4.3063 | -18.45% |
| June, 2030 | $4.9494 | $3.6476 | $6.1788 | +6.44% |
| July, 2030 | $5.1825 | $4.6301 | $5.2314 | +11.45% |
| August, 2030 | $6.1149 | $4.7431 | $6.3137 | +31.50% |
| September, 2030 | $4.8374 | $4.6274 | $5.7155 | +4.03% |
| October, 2030 | $3.6204 | $3.4292 | $4.528 | -22.14% |
| November, 2030 | $4.3015 | $2.85 | $4.5226 | -7.50% |
| December, 2030 | $4.2044 | $3.8944 | $5.2429 | -9.58% |
0.79%
3.50%
Cap:
|
Volume (24h):